Weldon B. Jolley

799 total citations
42 papers, 661 citations indexed

About

Weldon B. Jolley is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Weldon B. Jolley has authored 42 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Weldon B. Jolley's work include Immune Cell Function and Interaction (9 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Weldon B. Jolley is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Weldon B. Jolley collaborates with scholars based in United States, Netherlands and United Kingdom. Weldon B. Jolley's co-authors include Brahma S. Sharma, Ganesh D. Kini, David B. Hinshaw, Roland K. Robins, Howard B. Cottam, Donald F. Smee, Ganapathi R. Revankar, Steven S. Matsumoto, Daniel B. Hinshaw and R. K. ROBINS and has published in prestigious journals such as Nature, Analytical Biochemistry and American Journal of Epidemiology.

In The Last Decade

Weldon B. Jolley

41 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weldon B. Jolley United States 15 173 160 150 120 79 42 661
M Ghione Italy 16 77 0.4× 71 0.4× 253 1.7× 87 0.7× 43 0.5× 56 721
Steve L. Martin United Kingdom 13 223 1.3× 170 1.1× 375 2.5× 171 1.4× 251 3.2× 20 1.0k
Mitsuo Baba Japan 13 302 1.7× 57 0.4× 156 1.0× 134 1.1× 23 0.3× 19 756
T Shimamoto Japan 12 244 1.4× 79 0.5× 502 3.3× 69 0.6× 16 0.2× 27 922
Malini Bajpai India 15 157 0.9× 87 0.5× 292 1.9× 59 0.5× 26 0.3× 27 815
Jean‐Marc Périni France 18 126 0.7× 206 1.3× 455 3.0× 73 0.6× 45 0.6× 27 819
Günter Rosenfelder Switzerland 13 244 1.4× 103 0.6× 446 3.0× 123 1.0× 89 1.1× 17 860
Allen B. Clarkson United States 19 106 0.6× 108 0.7× 374 2.5× 603 5.0× 26 0.3× 32 977
Zoltan J. Lucas United States 19 492 2.8× 69 0.4× 549 3.7× 98 0.8× 86 1.1× 54 1.3k
Kimberly M. Sogi United States 9 189 1.1× 65 0.4× 246 1.6× 230 1.9× 36 0.5× 10 623

Countries citing papers authored by Weldon B. Jolley

Since Specialization
Citations

This map shows the geographic impact of Weldon B. Jolley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weldon B. Jolley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weldon B. Jolley more than expected).

Fields of papers citing papers by Weldon B. Jolley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weldon B. Jolley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weldon B. Jolley. The network helps show where Weldon B. Jolley may publish in the future.

Co-authorship network of co-authors of Weldon B. Jolley

This figure shows the co-authorship network connecting the top 25 collaborators of Weldon B. Jolley. A scholar is included among the top collaborators of Weldon B. Jolley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weldon B. Jolley. Weldon B. Jolley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kardol, Marrie J., et al.. (1993). A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA‐A2 subtypes and HLA‐A28. Tissue Antigens. 42(1). 27–34. 21 indexed citations
4.
Sharma, Brahma S., et al.. (1991). Successful immunotherapy of murine melanoma metastases with 7-thia-8-oxoguanosine. Clinical & Experimental Metastasis. 9(5). 429–439. 5 indexed citations
5.
Parandoosh, Zahra, Boanerges Rubalcava, Steven S. Matsumoto, Weldon B. Jolley, & Roland K. Robins. (1990). Changes in diacylglycerol and cyclic GMP during the differentiation of human myeloid leukemia K562 cells. Life Sciences. 46(4). 315–320. 10 indexed citations
6.
Anderson, Jack D., et al.. (1990). Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-.beta.-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents. Journal of Medicinal Chemistry. 33(1). 407–415. 78 indexed citations
7.
Sanghvi, Yogesh S., Ganesh D. Kini, Steven S. Matsumoto, et al.. (1990). Growth inhibition and induction of cellular differentiation of human myeloid leukemia cells in culture by carbamoyl congeners of ribavirin. Journal of Medicinal Chemistry. 33(1). 336–344. 81 indexed citations
8.
9.
Bontems, Roger J., et al.. (1990). Guanosine analogs. Synthesis of nucleosides of certain 3-substituted 6-aminopyrazolo[3,4-d]pyrimidin-4(5H)-ones as potential immunotherapeutic agents. Journal of Medicinal Chemistry. 33(8). 2174–2178. 21 indexed citations
10.
Matsumoto, Steven S., L. Dee Nord, Randall C. Willis, et al.. (1990). Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides. Biochemical Pharmacology. 39(3). 455–462. 6 indexed citations
11.
Jolley, Weldon B., et al.. (1990). A novel guanosine analog, 7-thia-8-oxoguanosine, enhances macrophage and lymphocyte antibody-dependent cell-mediated cytotoxicity. Cellular Immunology. 126(2). 414–419. 11 indexed citations
12.
Ojo-Amaize, Emmanuel A., Boanerges Rubalcava, Thomas L. Avery, et al.. (1990). Activation of the respiratory burst in murine phagocytes by certain guanine ribonucleosides modified at the 7 and 8 positions: possible involvement of a pertussis toxin-sensitive G-protein. Immunology Letters. 23(3). 173–178. 12 indexed citations
13.
Smee, Donald F., et al.. (1990). Antiviral activity of the novel immune modulator 7-thia-8-oxoguanosine.. PubMed. 9(1). 24–32. 18 indexed citations
14.
Sharma, Brahma S., et al.. (1990). Low molecular weight human T-cell response immunopotentiator: α-2'-deoxy-3-deazaguanosine. International Journal of Immunopharmacology. 12(6). 579–587. 1 indexed citations
15.
Jolley, Weldon B.. (1990). Modification of midtarsal osteotomy.. PubMed. 28(3). 191–4. 2 indexed citations
16.
Parandoosh, Zahra, et al.. (1989). Stimulation of phosphoinositide signaling pathway in murine B lymphocytes by a novel guanosine analog, 7-thia-8-oxoguanosine. Biochemical and Biophysical Research Communications. 163(3). 1306–1311. 3 indexed citations
17.
Ojo-Amaize, Emmanuel A., Zahra Parandoosh, Howard B. Cottam, et al.. (1989). Nucleoside and nucleotide modulation of genetic expression — A new approach to chemotherapy. Advances in Enzyme Regulation. 29. 97–121. 9 indexed citations
18.
SMEE, D. F., et al.. (1989). Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent. Antimicrobial Agents and Chemotherapy. 33(9). 1487–1492. 42 indexed citations
19.
Bailey, Leonard L., Jun Ho Jang, Walter D. Johnson, & Weldon B. Jolley. (1985). Orthotopic cardiac xenografting in the newborn goat. Journal of Thoracic and Cardiovascular Surgery. 89(2). 242–247. 30 indexed citations
20.
Hinshaw, David B., et al.. (1981). Islet autotransplantation after pancreatectomy for chronic pancreatitis with a new method of islet preparation. The American Journal of Surgery. 142(1). 118–122. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026